Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02720419 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IRIS-Synergy Cohort in the IRIS-DES Registry

Study acronym: IRIS Synergy
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 29 to 28 Completion date: Jun 2028 to Feb 2027v10 Show 1 more changeShow less
    • Completion date: Jun 2028 to Feb 2027
  2. Primary completion date changed from estimate of Jan 2023 to Feb 24, 2023 Completion date: Jan 2027 to Jun 2028v9 Show 1 more changeShow less
    • Completion date: Jan 2027 to Jun 2028
  3. Trial status: Recruiting to Active, Not Recruiting Primary completion date: Dec 2022 to Jan 2023 · Completion date: Dec 2026 to Jan 2027 · Site details revised at 29 of 29 sitesv8 Show 3 more changesShow less
    • Primary completion date: Dec 2022 to Jan 2023
    • Completion date: Dec 2026 to Jan 2027
    • Site details revised at 29 of 29 sites
  4. Secondary endpoints: 9 to 10v7 See this version in full on ClinicalTrials.gov ↗
  5. Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Dec 2020 to Dec 2022 Completion date: Jun 2025 to Dec 2026 · Secondary endpoints: details revised at 9 of 9 entries · Study sites revised (29)v5 Show 3 more changesShow less
    • Completion date: Jun 2025 to Dec 2026
    • Secondary endpoints: details revised at 9 of 9 entries
    • Study sites revised (29)

    See this version in full on ClinicalTrials.gov ↗

  2. Study sites: 28 to 29v4
  3. Enrollment target: 1000 to 3000 Site details revised at 10 of 28 sitesv3 Show 1 more changeShow less
    • Site details revised at 10 of 28 sites
  4. Trial status: Not Yet Recruiting to Recruiting Start date: Apr 2016 to Aug 2016 · Study sites: 1 to 28v2 Show 2 more changesShow less
    • Start date: Apr 2016 to Aug 2016
    • Study sites: 1 to 28
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.
Trial Details
NCT Number NCT02720419
Lead Sponsor Jung-min Ahn
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov